Lauren Giannetti Sferrazza MS, LGC

(she/her/hers) | GC | MSL Director | opinions are my own |#lgbtqiaally #blm #gcswithdisabilities #genechat

[Mark Lewis, MD, FASCO @marklewismd]

Cheers, chills, and a standing ovation when RASolute 302 showed unprecedented survival on daraxonrasib for patients with progressive pancreatic cancer

Seldom do you sense you’re witnessing a historic moment in cancer care but this feels like ras targeting has arrived

#ASCO26

[Lauren Giannetti Sferrazza MS, LGC @LGtheCGC]

It feels good to be back! My first ASCO with @adela_bio and post-baby . I’m absorbing all the amazing content and trying to connect with my peers and clinicians! #asco26 #tissuefreemrd

[Adela @adela_bio]

Adela is advancing methylome analysis to deliver sensitive, blood-based ctDNA testing options for patients with cancer. By enabling earlier detection and more precise monitoring of cancer, we help clinicians and biopharma partners make more confident, informed decisions
#ASCO26

[Adela @adela_bio]

We’re excited to share that Adela will highlight progress from our MCED study @ASCO 2026.

https://t.co/wvbFhmrNup

#ASCO26

[OncoDaily @oncodaily]

New Updates on Recurrence Detection in Head and Neck Cancer - Elizabeth Lightbody

@adela_bio

https://t.co/PeQxMJlyjE

#OncoDaily #ASCO

[ASTRO @ASTRO_org]

Happy Thursday, #MHNCS26! Day 1's highlights include the first Keynote from Sana Karam, MD, PhD, a Patient Perspective from Hector Basham, the K. Kian Ang, MD, PhD, FASTRO, Commemorative Plenary Session, and more!

View the schedule: https://t.co/hu6Y71Z56K

[Lauren Giannetti Sferrazza MS, LGC @LGtheCGC]

We love seeing a #geneticcounselor as a top leader! Congrats! @GeneticCouns

[Natera @NateraGenetics]

Sheetal Parmar, SVP of medical affairs, women’s health, has been recognized as one of the 2025 Top 50 Women Leaders in Healthcare Technology by The Healthcare Technology Report. 👏 The annual distinction highlights leaders who are shaping the future of healthcare through scientific advancement, operational excellence and meaningful patient impact.

Since joining Natera in 2013, Sheetal has been instrumental in strengthening the clinical foundation of our women’s health portfolio. A board-certified genetic counselor specializing in prenatal diagnosis and screening, she leads a multidisciplinary medical affairs organization and plays a critical role in guiding clinical strategy, enhancing the design and execution of the clinical trials and shaping Natera's approach to educating and serving patients and their providers. Her leadership reflects a deep commitment to advancing standards of care and expanding access to innovative genetic testing.

Please join us in congratulating Sheetal on this outstanding achievement!

https://t.co/IJL0mvHKpN

[Lauren Giannetti Sferrazza MS, LGC @LGtheCGC]

Good morning #mhncs26 ! #adela

[Lauren Giannetti Sferrazza MS, LGC @LGtheCGC]

I’m back!!!! First conference post-baby with my new company #adela come visit me at the booth to hear about tissue-free ctDNA MRD testing for HNSCC HPV+\- cancer #mhncs26 #hnscc #astro #oncology #mrd

[Grant McKenzie M.D. @GrantMcKenz]

Gearing up for a packed first day of exciting presentations at #MHNCS26! @ASTRO_org

[Lauren Giannetti Sferrazza MS, LGC @LGtheCGC]

Another great poster from @myriadgenetics - reporting the HRD status of patients in a research registry #sgomeeting #sgo25

[Lauren Giannetti Sferrazza MS, LGC @LGtheCGC]

So proud of @myriadgenetics poster from our patient registry - check out our poster on the prevalence of germline PVs in EC >50 #SGOMtg #sgo2025 #myriadgenetics #hereditarycancer

[Lauren Giannetti Sferrazza MS, LGC @LGtheCGC]

Having a serious case of FOMO while on mat leave during #SGOMtg #sgo2025 thanks to @ShannonWestin I feel like I’m right there with everyone !!!

[Shannon Westin, MD, MPH, FASCO @ShannonWestin]

🔥♥️🤩👏Inspiring talk to #MultiplyYourImpact by @amandanfader at #SGOMtg #SGO2025

🔥🔥🔥An awesome @SGO_org president in a time of uncertainty!!!

[Nicole D. Fleming MD @nicoleflemingmd]

🔥🔥Hear our @SGO_org expert Dr. Kathleen Moore discuss #impact of DUO-E regimen in MMR-proficient #endometrialcancer with biomarker stratification @ShannonWestin @amandanfader #SGOMtg #SGO2025

[CGA-IGC @CGAIGC]

📢For #BlackHistoryMonth, we are highlighting @BlackInGenetics, an organization “dedicated to amplifying the voices and work of Black-identifying geneticists across the U.S”

➡️Learn more 👉https://t.co/UeVzEK0nK6

#AdvancingCommitments #HereditaryGICancer
@yvonnerms @LGtheCGC

[Lauren Giannetti Sferrazza MS, LGC @LGtheCGC]

Love these definitions @CGAIGC #CGAIGC24 important when providing gender inclusive care

[Lauren Giannetti Sferrazza MS, LGC @LGtheCGC]

Last day at @CGAIGC conference, #CGAIGC24 baby G has been behaving - kicking away and enjoying all the sessions- 33 weeks and he is already becoming a @CGAIGC fellow

[CGA-IGC @CGAIGC]

Welcome to the last day of #CGAIGC24! Don't miss President Bryson Katona's final welcome, starting in 10 minutes!

[Ed Esplin, MD, PhD @EdEsplin]

"Insurance coverage and denials of guideline-recommended #colorectalcancer #genetictesting" poster @CGAIGC #CGAIGC24

Of all #germlinetesting denials for #CRC #patients diagnosed <50yo, 35% denied coverage for 'not medically necessary' 'non-covered service' 'experimental/investigational', despite @NCCN recommendation of #universal #genetictesting for all #CRC #patients diagnosed <50yo

Appeals overturned denials for 41% of #patients diagnosed <50yo

#access #reducedisparities #precisionmedicine #precisiontherapy #clinicaltrials #precisionprevention @Invitae @Labcorp

[Lauren Giannetti Sferrazza MS, LGC @LGtheCGC]

So interesting - takeaways from CDH1 25 years of research- 90+% of pt have signet ring cells but only 10-40% go on to develop cancer. EUS is safe alt to total Gastrectomy 😱😱 @CGAIGC #cgaigc24